Category Archives: Salud Infantil

Aumento de la mortalidad infantil en Argentina


La tasa de mortalidad infantil en Argentina se incrementó en 2007 respecto del índice de 12,9 registrado en 2006 y se ubicó en 13,3 cada 1.000 nacidos vivos, a causa de enfermedades respiratorias y septicemias. La tasa fue reportada por … Continue reading

Posted in Argentina, mortalidad, Salud Infantil | Leave a comment

Determinantes Sociales de la Salud – OMS –


La justicia social es una cuestión de vida o muerte.Afecta al modo en que vive la gente, a la probabilidad de enfermar y al riesgo de morir de forma prematura.Vemos maravillados como la esperanza de vida y el estado de … Continue reading

Posted in Determinantes sociales de la salud, documento, inequidad, Lejarraga, OMS, Salud Infantil | Leave a comment

Determinantes Sociales de la Salud – OMS –


La justicia social es una cuestión de vida o muerte.Afecta al modo en que vive la gente, a la probabilidad de enfermar y al riesgo de morir de forma prematura.Vemos maravillados como la esperanza de vida y el estado de … Continue reading

Posted in Determinantes sociales de la salud, documento, inequidad, Lejarraga, OMS, Salud Infantil | Leave a comment

Estarán prohibidas en Canada los biberones de policarbonato


Estarán prohibidas en Canadá los biberones de policarbonato El plástico contiene bisfenol-a, una sustancia química declarada tóxica Lunes 21 de abril de 2008 | Publicado en la Edición impresa OTTAWA ( The New York Times ).- El gobierno de Canadá … Continue reading

Posted in Salud Infantil | Tagged , , , , | 6 Comments

Hipnoterapia é efetiva para dor abdominal funcional e cólon irritável em crianças


Hipnoterapia é efetiva para dor abdominal funcional e cólon irritável em crianças Questão clínica A hipnoterapia melhora os sintomas da dor abdominal funcional em crianças? Resumo Esse pequeno, mas bem projetado, ensaio concluiu que hipnoterapia é um tratamento efetivo para … Continue reading

Posted in Salud Infantil | Tagged , , , , | Leave a comment

Antibióticos orales versus parenterales para la neumonia grave en niños


Antibióticos orales versus parenterales para la neumonía grave en niños (Revisión Cochrane traducida) Rojas MX, Granados C Fecha de la modificación significativa más reciente: 20 de enero de 2006. Las revisiones Cochrane se revisan regularmente y se actualizan si es … Continue reading

Posted in Colaboracion Cochrane, Respiratorio, Revision Sistematica, Salud Infantil | Tagged , , , , , | Leave a comment

Evaluación clínica retrospectiva del manejo del traumatismo craneal. La radiografía de cráneo parece prescindible si se dispone de tomografía computarizada


Artículos relacionados en EvidPediatr PubMed sobre este tema Scholar sobre este tema Artículo en pdf Versión para imprimir Buscar: autor: claves: Búsqueda avanzada Referencia Bibliográfica: Can we abolish skull x rays for head injury? M J Reed, J G Browning, … Continue reading

Posted in Evidencias en Pediatria, Examenes complementarios, Salud Infantil, trauma | Tagged , , , , , | Leave a comment

Fototerapia para la ictericia neonatal


M. Jeffrey Maisels, M.B., B.Ch., and Antony F. McDonagh, Ph.D. PDF PDA Full Text PowerPoint Slide Set CME Exam Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation <!– … Continue reading

Posted in Salud Infantil, tratamiento | Tagged , , , , , | Leave a comment

En las reagudizaciones del asma, el aumento de las dosis previas de corticoides inhalados no produce beneficio


  Artículos relacionados en EvidPediatr PubMed sobre este tema Scholar sobre este tema Artículo en pdf Versión para imprimir Buscar: autor: claves: Búsqueda avanzada University of Michigan Department of Pediatrics Evidence-Based Pediatrics Web Site. Critically Appraised Topics (Temas Valorados Críticamente). … Continue reading

Posted in Asma, pediatria, Salud Infantil | Tagged , , , , | Leave a comment

Shared care by paediatric oncologists and family doctors for long-term follow-up of adult childhood cancer survivors: a pilot study


Lancet Oncology 2008; 9:232-238 DOI:10.1016/S1470-2045(08)70034-2 Articles Dr Ria Blaauwbroek MD  a ,   Wemke Tuinier RN a,   Prof Betty Meyboom-de Jong PhD b,   Prof Willem A Kamps PhD a   and   Aleida Postma PhD a Summary Background Since 75% of children with cancer will become long-term survivors, late effects of … Continue reading

Posted in Cancer, medicina familiar, medicina general, Salud Infantil | Tagged , , , , , | 1 Comment

Pediatrics in Review: Marzo 2008


Download March 2008 Managing Sports Injuries in the Pediatric Office Recognition of Autism Before Age 2 Years Index of Suspicion Posttraumatic Stress Disorder Enteral Feeding American Academy of Pediatrics Policy Statements on Bioethics: Summaries and Commentaries: Part 2 NeoReviews

Posted in Biblioteca virtual, pediatria, Salud Infantil | Tagged , , , , , , | Leave a comment

En niños con otitis media serosa, los tubos de drenaje timpanico producen una escasa mejoría en la audicion y en la duracion del derrame


  Artículos relacionados en EvidPediatr PubMed sobre este tema Scholar sobre este tema Artículo en pdf Referencia bibliográfica : Lous J, Burton MJ, Felding JU, Ovesen T, Rovers MM, Williamson I. Drenajes timpánicos (tubos de ventilación) para la pérdida de … Continue reading

Posted in otitis media aguda, pronostico, Salud Infantil, tratamiento | Tagged , , , , , | 1 Comment

Escrutinio neonatal para la detección de problemas auditivos


Opciones Artículos relacionados en EvidPediatr PubMed sobre este tema Scholar sobre este tema Artículo en pdf Versión para imprimir Procedencia: University of York. Centre for Reviews and Dissemination (CRD). Health Technology Assessment (HTA) Database. Copyright © Institut fuer Qualitaet und … Continue reading

Posted in pediatria, Salud Infantil | Tagged , , , , , | Leave a comment

Pediatrics Online Early Release Alert


Pediatrics Online Early Release Alert New Pediatrics Early Release articles have been made available (for the period 30 Jan 2008 to 4 Feb 2008): ARTICLES Neuroradiographic, Endocrinologic, and Ophthalmic Correlates of Adverse Developmental Outcomes in Children With Optic Nerve Hypoplasia: … Continue reading

Posted in Salud Infantil | Tagged , , , , , | Leave a comment

Manual de Intoxicaciones en Pediatría


Sociedad Española de Urgencias en Pediatria ÍNDICE 35 capitulos Autores Prólogo Introducción Epidemiología de las intoxicaciones en pediatría Consulta telefónica Descontaminación gastrointestinal: carbón activado Descontaminación gastrointestinal: alternativas y/o complementos al carbón activado Antídotos más utilizados en intoxicaciones pediátricas Pruebas de … Continue reading

Posted in Salud Infantil, Toxicologia | Tagged , , , , , | Leave a comment

Los hijos de gestantes fumadoras tardan entre tres y seis años en alcanzar los parámetros de crecimiento de los de las no fumadoras


Referencia: Kanellopoulos TA, Varvarigou AA, Karatza AA, Beratis NG. Course of growth during the first 6 years in children exposed in utero to tobacco smoke. Eur J Pediatr. 2007;16:685-92. Revisores: Alejandro Suwezda. Pediatra independiente. Tarragona (España). Correo electrónico: suwezda@gmx.de Ariel … Continue reading

Posted in pediatria, Salud Infantil, Salud materno-infantil | Tagged , , , , , | Leave a comment

JAMA: tiene este niño una infeccion del tracto urinario?


Does This Child Have a Urinary Tract Infection? Nader Shaikh, MD, MPH; Natalia E. Morone, MD, MSc; John Lopez, MD; Jennifer Chianese, MD, MSc; Shilpa Sangvai, MD, MPH; Frank D’Amico, PhD; Alejandro Hoberman, MD; Ellen R. Wald, MD JAMA. 2007;298(24):2895-2904. Context  … Continue reading

Posted in infeccion urinaria, Salud Infantil | Tagged , , , , , | Leave a comment

Correo de la Sociedad Argentina de Pediatria


Comentarios Reflexiones sobre la inutilidad del tratamiento médico Dra. Adriana V. Scrigni Arch Argent Pediatr 2007; 105(5):385-386 http://www.sap.org.ar/staticfiles/archivos/2007/arch07_5/v105n5a01.pdf Sobre la desproporcionalidad de la atención médica Dra. Norma Rossato 386 Arch Argent Pediatr 2007; 105(5):387-388 http://www.sap.org.ar/staticfiles/archivos/2007/arch07_5/v105n5a02.pdf El pediatra en los tiempos … Continue reading

Posted in Salud Infantil | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Archivo de temas valorados criticamente sobre utilidad de pruebas diagnósticas


Fuente: Pediatria Basada en la Evidencia  Cardiología pediátrica: La radiografía de tórax no es útil para descartar la presencia de cardiopatía en niños asintomáticos que presentan un soplo cardiaco Gastroenterología pediátrica: En niños con un cuadro clínico compatible con enfermedad … Continue reading

Posted in Medicina Basada en la Evidencia, Salud Infantil | Tagged , , , , , , , , , , | Leave a comment

Pediatria Basada en la Evidencia


Adolescentes y drogas. Un reto para los profesionales sanitarios Hidalgo Vicario MI, Redondo Romero A. Evid Pediatr. 2007;3:60. [HTM] [PDF] Papel protector de la lactancia materna en las infecciones de la infancia: análisis crítico de la metodología de estudio Paricio … Continue reading

Posted in Medicina Basada en la Evidencia, Salud en Adolescentes, Salud Infantil | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 1 Comment

Estudio SMART: salmeterol y asma A Comparison of Usual Pharmacotherapy for Asthma or Usual Pharmacotherapy Plus Salmeterol Harold S. Nelson, MD; Scott T. Weiss, MD, MS; Eugene R. Bleecker, MD; Steven W. Yancey, MS; Paul M. Dorinsky, MD; the SMART Study Group * From the National Jewish Medical and Research Center (Dr. Nelson), Denver, CO; Brigham and Women’s Hospital and Harvard Medical School (Dr. Weiss), Boston, MA; Wake Forest University School of Medicine (Dr. Bleecker), Winston Salem, NC; and GlaxoSmithKline (Mr. Yancey and Dr. Dorinsky), Research Triangle Park, NC.More… Correspondence to: Paul M. Dorinsky, MD, GlaxoSmithKline, 5 Moore Dr, Research Triangle Park, NC 27709; e-mail: paul.m.dorinsky@gsk.com Abstract Study objective: To compare the safety of salmeterol xinafoate or placebo added to usual asthma care. Design: A 28-week, randomized, double-blind, placebo-controlled, observational study. Setting: Study subjects were seen once in the study physician’s office for screening and were provided all blinded study medication for the entire study period. Follow-up by telephone was scheduled every 4 weeks. Participants: Subjects (> 12 years old) with asthma as judged by the study physician were eligible. Individuals with a history of long-acting ß2-agonist use were excluded. Interventions: Salmeterol, 42 µg bid via metered-dose inhaler (MDI), and placebo bid via MDI. Measurements and results: Following an interim analysis in 26,355 subjects, the study was terminated due to findings in African Americans and difficulties in enrollment. The occurrence of the primary outcome, respiratory-related deaths, or life-threatening experiences was low and not significantly different for salmeterol vs placebo (50 vs 36; relative risk [RR] = 1.40; 95% confidence interval [CI], 0.91 to 2.14). There was a small, significant increase in respiratory-related deaths (24 vs 11; RR, 2.16; 95% CI, 1.06 to 4.41) and asthma-related deaths (13 vs 3; RR, 4.37; 95% CI, 1.25 to 15.34), and in combined asthma-related deaths or life-threatening experiences (37 vs 22; RR, 1.71; 95% CI, 1.01 to 2.89) in subjects receiving salmeterol vs placebo. The imbalance occurred largely in the African-American subpopulation: respiratory-related deaths or life-threatening experiences (20 vs 5; RR, 4.10; 95% CI, 1.54 to 10.90) and combined asthma-related deaths or life-threatening experiences (19 vs 4; RR, 4.92; 95% CI, 1.68 to 14.45) in subjects receiving salmeterol vs placebo. Conclusions: For the primary end point in the total population, there were no significant differences between treatments. There were small, but statistically significant increases in respiratory-related and asthma-related deaths and combined asthma-related deaths or life-threatening experiences in the total population receiving salmeterol. Subgroup analyses suggest the risk may be greater in African Americans compared with Caucasian subjects. Whether this risk is due to factors including but not limited to a physiologic treatment effect, genetic factors, or patient behaviors leading to poor outcomes remains unknown. Estudio SMART: The Salmeterol Multicenter Asthma Research Trial


The Salmeterol Multicenter Asthma Research Trial A Comparison of Usual Pharmacotherapy for Asthma or Usual Pharmacotherapy Plus Salmeterol Harold S. Nelson, MD; Scott T. Weiss, MD, MS; Eugene R. Bleecker, MD; Steven W. Yancey, MS; Paul M. Dorinsky, MD; the … Continue reading

Posted in Asma, Medicamentos, mortalidad, Salud Infantil | Tagged , , , , | Leave a comment

Estudio SMART: salmeterol y asma A Comparison of Usual Pharmacotherapy for Asthma or Usual Pharmacotherapy Plus Salmeterol Harold S. Nelson, MD; Scott T. Weiss, MD, MS; Eugene R. Bleecker, MD; Steven W. Yancey, MS; Paul M. Dorinsky, MD; the SMART Study Group * From the National Jewish Medical and Research Center (Dr. Nelson), Denver, CO; Brigham and Women’s Hospital and Harvard Medical School (Dr. Weiss), Boston, MA; Wake Forest University School of Medicine (Dr. Bleecker), Winston Salem, NC; and GlaxoSmithKline (Mr. Yancey and Dr. Dorinsky), Research Triangle Park, NC.More… Correspondence to: Paul M. Dorinsky, MD, GlaxoSmithKline, 5 Moore Dr, Research Triangle Park, NC 27709; e-mail: paul.m.dorinsky@gsk.com Abstract Study objective: To compare the safety of salmeterol xinafoate or placebo added to usual asthma care. Design: A 28-week, randomized, double-blind, placebo-controlled, observational study. Setting: Study subjects were seen once in the study physician’s office for screening and were provided all blinded study medication for the entire study period. Follow-up by telephone was scheduled every 4 weeks. Participants: Subjects (> 12 years old) with asthma as judged by the study physician were eligible. Individuals with a history of long-acting ß2-agonist use were excluded. Interventions: Salmeterol, 42 µg bid via metered-dose inhaler (MDI), and placebo bid via MDI. Measurements and results: Following an interim analysis in 26,355 subjects, the study was terminated due to findings in African Americans and difficulties in enrollment. The occurrence of the primary outcome, respiratory-related deaths, or life-threatening experiences was low and not significantly different for salmeterol vs placebo (50 vs 36; relative risk [RR] = 1.40; 95% confidence interval [CI], 0.91 to 2.14). There was a small, significant increase in respiratory-related deaths (24 vs 11; RR, 2.16; 95% CI, 1.06 to 4.41) and asthma-related deaths (13 vs 3; RR, 4.37; 95% CI, 1.25 to 15.34), and in combined asthma-related deaths or life-threatening experiences (37 vs 22; RR, 1.71; 95% CI, 1.01 to 2.89) in subjects receiving salmeterol vs placebo. The imbalance occurred largely in the African-American subpopulation: respiratory-related deaths or life-threatening experiences (20 vs 5; RR, 4.10; 95% CI, 1.54 to 10.90) and combined asthma-related deaths or life-threatening experiences (19 vs 4; RR, 4.92; 95% CI, 1.68 to 14.45) in subjects receiving salmeterol vs placebo. Conclusions: For the primary end point in the total population, there were no significant differences between treatments. There were small, but statistically significant increases in respiratory-related and asthma-related deaths and combined asthma-related deaths or life-threatening experiences in the total population receiving salmeterol. Subgroup analyses suggest the risk may be greater in African Americans compared with Caucasian subjects. Whether this risk is due to factors including but not limited to a physiologic treatment effect, genetic factors, or patient behaviors leading to poor outcomes remains unknown. Estudio SMART: The Salmeterol Multicenter Asthma Research Trial


The Salmeterol Multicenter Asthma Research Trial A Comparison of Usual Pharmacotherapy for Asthma or Usual Pharmacotherapy Plus Salmeterol Harold S. Nelson, MD; Scott T. Weiss, MD, MS; Eugene R. Bleecker, MD; Steven W. Yancey, MS; Paul M. Dorinsky, MD; the … Continue reading

Posted in Asma, Medicamentos, mortalidad, Salud Infantil | Tagged , , , , , | Leave a comment

Pediatria


1st edition By Janner, Donald Download Clinical Guide to Pediatric Infectious Disease PASSWORD FOR OPEN RAR FILE IS http://medicalbooks4everyone.blogspot.com/

Posted in Biblioteca virtual, Infectologia, Salud Infantil | Tagged , , , , | Leave a comment

* Deteccion de enfermedades congenitas * Proyecto de normativa para celiacos en el Partido de Pehuajó (prov. Bs. As.) * We stand all toguether * Vacuna antineumococcica Salud en niños


Deteccion de enfermedades congenitas Proyecto de normativa para celiacos en el Partido de Pehuajó (prov. Bs. As.) We stand all toguether Vacuna antineumococcica Fuente: http://pedamb.wordpress.com

Posted in Salud Infantil | Tagged , , , , , , , , | Leave a comment

* Deteccion de enfermedades congenitas * Proyecto de normativa para celiacos en el Partido de Pehuajó (prov. Bs. As.) * We stand all toguether * Vacuna antineumococcica Salud en niños


Deteccion de enfermedades congenitas Proyecto de normativa para celiacos en el Partido de Pehuajó (prov. Bs. As.) We stand all toguether Vacuna antineumococcica Fuente: http://pedamb.wordpress.com

Posted in Salud Infantil | Tagged , , , , , , , | Leave a comment

Abuso infantil y violencia domestica


Pediatricians and other health-care professionals are uniquely positioned to identify victims of domestic violence and child abuse within the same family and to offer potentially lifesaving assistance. Among 3 million cases of child abuse reported each year in the United … Continue reading

Posted in Salud Infantil, Violencia domestica | Tagged , , , , , | 2 Comments

Intussusception After Administration of the Rhesus Tetravalent Rotavirus Vaccine (Rotashield): The Search for a Pathogenic Mechanism.


Maureen Lynch, Wun-Ju Shieh, Joseph S. Bresee, Kathleen M. Tatti, Jon R. Gentsch, Tara Jones, Baoming Jiang, Erik Hummelman, Christopher M. Zimmerman, Sherif R. Zaki, and Roger I. Glass Intussusception After Administration of the Rhesus Tetravalent Rotavirus Vaccine (Rotashield): The … Continue reading

Posted in Infectologia, Inmmunizacion, Prevencion, Rotavirus, Salud Infantil | Tagged , , , , , , | 2 Comments

Papel protector de la lactancia materna en las infecciones de la infancia: análisis crítico de la metodología de estudio


Papel protector de la lactancia materna en las infecciones de la infancia: análisis crítico de la metodología de estudio Final del formulario Autor: José María Paricio Talayero. Servicio de Pediatría. Hospital Marina Alta, Denia. Alicante (España). Diplomado en Diseño y … Continue reading

Posted in Evidencias en Pediatria, Lactancia materna, Medicina Basada en la Evidencia, Prevencion, Salud Infantil, Salud materno-infantil | Tagged , , , , , | Leave a comment

Duración óptima de la lactancia materna exclusiva


Duración óptima de la lactancia materna exclusiva (Revisión Cochrane traducida) Kramer MS, Kakuma R   Fecha de la modificación significativa más reciente: 21 de noviembre de 2001. Las revisiones Cochrane se revisan regularmente y se actualizan si es necesario. RESUMEN … Continue reading

Posted in Colaboracion Cochrane, Lactancia materna, Salud Infantil | Tagged , , | 1 Comment